Skip to content

McKesson MCK Deferred Taxes

Deferred Taxes at other companies

Eli Lilly logo
Eli LillyLLY
$1.48B+277%
Cardinal Health logo
Cardinal HealthCAH
$60.75M+334%
Cencora logo
CencoraCOR
$178.41M+581%
AbbVie logo
AbbVieABBV
$137M+589%
Viatris logo
ViatrisVTRS
-$69.7M-59.9%
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$88.46B+2.1%
Enterprise value$86.77B-8.5%
P/E18.6×-8.8×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredIncomeTaxes.

The official record: McKesson’s 10-Q, filed February 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's deferred taxes?
McKesson (MCK) reported deferred taxes of -$49M in Q4 2025.
How has McKesson's deferred taxes changed year-over-year?
McKesson's deferred taxes decreased by 96.0% year-over-year, from -$25M to -$49M.
What is the long-term trend for McKesson's deferred taxes?
Over 3 years (2022 to 2025), McKesson's deferred taxes has grown at a 47.9% compound annual growth rate (CAGR), from -$34M to $110M.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.